Health / Medical Topics

    GM-CSF-encoding Oncolytic Adenovirus CGTG-102

    A recombinant, oncolytic serotype 5/3 capsid-modified adenovirus encoding the immunostimulatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) with potential antineoplastic activity. Upon administration, the oncolytic adenovirus selectively infects and replicates in tumor cells, which may result in tumor cell lysis. Synergistically, GM-CSF (sargramostim) expressed by the oncolytic adenovirus enhances antigen presentation, promotes natural killer (NK) cell-mediated killing and causes a cytotoxic T cell (CTL) response against tumor cells harboring the oncolytic adenovirus, resulting in an immune-mediated tumor cell death. CGTG-102 is designed to replicate only in cells with defects in the p16/Rb/E2F pathway, attributed to a mutation common in many solid tumors. Replacement of the Ad5 capsid protein knob with a knob domain from serotype 3 causes higher transduction in cancer cells as compared to normal cells. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Heterodimeric human GM-CSF Receptor is composed of Colony Stimulating Factor 2 Receptor Alpha Chain and Colony Stimulating Factor 2 Receptor Beta…
    DNA that encodes granulocyte-macrophage colony stimulating factor (GM-CSF). GM-CSF enhances the host immune response to poorly immunogenic tumors, possibly by activating…
    Expression vectors containing the complementary DNA (cDNA) of the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) coated onto gold particles. A protein cytokine…
    A substance that helps make more white blood cells, especially granulocytes, macrophages, and cells that become platelets. It is a cytokine that…
    A sulfonamide derivative with antihyperglycemic activity. Like sulfonylureas, glysobuzole is able to lower blood glucose levels by increasing the release of insulin…
    A sulfonamide derivative with antihyperglycemic activity. Like sulfonylureas, glyprothiazol is able to lower blood glucose levels by increasing the release of insulin…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact